E-LIB Suche - Ergebnisse für: Fusco, Jennifer S.

1

Improving Adherence to the Target Window for Cabotegravir +..:

Wohlfeiler, Michael B. ; Brunet, Laurence ; Cochran, Quateka...
Journal of the International Association of Providers of AIDS Care (JIAPAC). 23 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

2

Cabotegravir + Rilpivirine Long-Acting Injections for HIV T..:

Sension, Michael G. ; Brunet, Laurence ; Hsu, Ricky K....
Infectious Diseases and Therapy. 12 (2023) 12 - p. 2807-2817 , 2023

Link: https://doi.org/10.1007/..

3

1028. Real-World Use of Long-Acting Cabotegravir + Rilpivir..:

Hsu, Ricky K ; Sension, Michael ; Fusco, Jennifer S...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

1608. Real-World Effectiveness of Long-Acting Cabotegravir ..:

Sension, Michael ; Hsu, Ricky K ; Fusco, Jennifer S...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

5

Immune response to ART initiation in advanced HIV infection:

Mounzer, Karam ; Brunet, Laurence ; Fusco, Jennifer S....
HIV Medicine. 24 (2023) 6 - p. 716-726 , 2023

Link: https://doi.org/10.1111/..

6

1023. Suppressed Switch to Bictegravir/Emtricitabine/Tenofo..:

Pierone Jr., Gerald ; Fusco, Jennifer S ; Brunet, Laurence...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

Heavily treatment-experienced people living with HIV in the..:

Hsu, Ricky K. ; Fusco, Jennifer S. ; Henegar, Cassidy E....
BMC Infectious Diseases. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

8

441. Association between Incident HIV-Associated Wasting/Lo..:

Wohlfeiler, Michael B ; Weber, Rachel P ; Brunet, Laurence...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

9

1284. Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- ..:

Pierone Jr., Gerald ; Fusco, Jennifer S ; Brunet, Laurence...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

10

HIV retention in care: results and lessons learned from the..:

Wohlfeiler, Michael B. ; Weber, Rachel Palmieri ; Brunet, Laurence...
BMC Primary Care. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

11

Dolutegravir/rilpivirine 2-drug regimen comparable to commo..:

Pierone Jr, Gerald ; Fusco, Jennifer S ; Vannappagari, Vani...
Antiviral Therapy. 27 (2022) 1 - p. 135965352110732 , 2022

Link: https://doi.org/10.1177/..

12

Advanced HIV Infection in Treatment-Naïve Individuals: Effe..:

Mounzer, Karam ; Brunet, Laurence ; Fusco, Jennifer S...
Open Forum Infectious Diseases. 9 (2022) 3 - p. , 2022

Link: https://doi.org/10.1093/..

13

1951. Guiding COVID-19 Booster Vaccinations by COVID-19 Qua..:

Hsu, Ricky K ; Brunet, Laurence ; Fusco, Jennifer S
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

14

1264. Durability and effectiveness of fostemsavir in heavil..:

Hsu, Ricky K ; Brunet, Laurence ; Fusco, Jennifer S...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

15

1582. Real-World Use of Long-Acting Cabotegravir + Rilpivir..:

Sension, Michael G ; Hsu, Ricky K ; Fusco, Jennifer S...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..